Isolation and structure elucidation of chlorofusin, a novel p53-MDM2 antagonist from a Fusarium sp.

被引：145

作者：

Duncan, SJ ^{[1
]}

Grüschow, S ^{[1
]}

Williams, DH ^{[1
]}

McNicholas, C ^{[1
]}

Purewal, R ^{[1
]}

Hajek, M ^{[1
]}

Gerlitz, M ^{[1
]}

Martin, S ^{[1
]}

Wrigley, SK ^{[1
]}

Moore, M ^{[1
]}

机构：

[1] Univ Cambridge, Cambridge Ctr Mol Recognit, Chem Lab, Cambridge CB2 1EW, England

来源：

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY | 2001年 / 123卷 / 04期

关键词：

D O I：

10.1021/ja002940p

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

Wild-type p53 plays a crucial role in the prevention of cancer. Since dysfunction of p53 can be caused by increased levels of the protein MDM2, small molecules which antagonize the interaction between these two-proteins have-potential in cancer therapy. The discovery and structure determination of a fungal metabolite, chlorofusin, which antagonizes the p53/MDM2 interaction are reported.

引用

页码：554 / 560

页数：7

共 16 条

[1] Bhacca NS., 1964, Applications of NMR Spectroscopy in Organic Chemistry
[2] Illustrations From the Steroid Field
[3] On the interaction between p53 and MDM2: Transfer NOE study of a p53-derived peptide ligated to MDM2
Blommers, MJJ
Fendrich, G
GarciaEcheverria, C
Chene, P
[J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1997, 119 (14) : 3425 - 3426
[4] The human oncoprotein MDM2 arrests the cell cycle: elimination of its cell-cycle-inhibitory function induces tumorigenesis
Brown, DR
Thomas, CA
Deb, SP
[J]. EMBO JOURNAL, 1998, 17 (09) : 2513 - 2525
[5] Overexpression of MDM2, due to enhanced translation, results in inactivation of wild-type p53 in Burkitt's lymphoma cells
Capoulade, C
Bressac-de Paillerets, B
Lefrère, I
Ronsin, M
Feunteun, J
Tursz, T
Wiels, J
[J]. ONCOGENE, 1998, 16 (12) : 1603 - 1610
[6] TUMORIGENIC POTENTIAL ASSOCIATED WITH ENHANCED EXPRESSION OF A GENE THAT IS AMPLIFIED IN A MOUSE-TUMOR CELL-LINE
FAKHARZADEH, SS
TRUSKO, SP
GEORGE, DL
[J]. EMBO JOURNAL, 1991, 10 (06) : 1565 - 1569
[7] BIOCHEMICAL-PROPERTIES AND BIOLOGICAL EFFECTS OF P53
HAFFNER, R
OREN, M
[J]. CURRENT OPINION IN GENETICS & DEVELOPMENT, 1995, 5 (01) : 84 - 90
[8] Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain
Kussie, PH
Gorina, S
Marechal, V
Elenbaas, B
Moreau, J
Levine, AJ
Pavletich, NP
[J]. SCIENCE, 1996, 274 (5289) : 948 - 953
[9] THE P53 TUMOR SUPPRESSOR GENE
LEVINE, AJ
MOMAND, J
FINLAY, CA
[J]. NATURE, 1991, 351 (6326) : 453 - 456
[10] THE MDM-2 ONCOGENE PRODUCT FORMS A COMPLEX WITH THE P53 PROTEIN AND INHIBITS P53-MEDIATED TRANSACTIVATION
MOMAND, J
ZAMBETTI, GP
OLSON, DC
GEORGE, D
LEVINE, AJ
[J]. CELL, 1992, 69 (07) : 1237 - 1245

← 1 2 →